Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
The Lancet. Haematology
|
September 30, 2017
Maintenance lenalidomide could be most relevant after first-line therapy
Julie E Chang
Drugs
|
November 17, 2011
Current status of targeted therapies for mantle cell lymphoma
Julie E Chang, Brad S Kahl
Current Hematologic Malignancy Reports
|
January 7, 2014
PI3-kinase inhibitors in chronic lymphocytic leukemia
Julie E Chang, Brad S Kahl
Leukemia & Lymphoma
|
January 7, 2012
Bendamustine: more ammunition in the battle against mantle cell lymphoma
Julie E Chang, Brad S Kahl
Clinical Advances in Hematology & Oncology : H&O
|
March 7, 2007
Therapeutic advances in the treatment of brain metastases
Julie E Chang, H Ian Robins, Minesh P Mehta
Clinical Lymphoma, Myeloma & Leukemia
|
June 11, 2011
Regression of Hodgkin lymphoma after discontinuation of a tumor necrosis factor inhibitor for Crohn's disease: a case report and review of the literature
Ryan D Cassaday, Jeffrey T Malik, Julie E Chang
Hematology Reports
|
December 21, 2011
Extranodal NK/T-cell lymphoma presenting with primary cardiac involvement
Lisa M Lepeak, David T Yang, Julie E Chang
Current Cancer Therapy Reviews
|
December 20, 2012
Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment
Ticiana Leal, Julie E Chang, Minesh Mehta, et al.
Clinical Advances in Hematology & Oncology : H&O
|
January 11, 2008
Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme
Julie E Chang, Deepak Khuntia, H Ian Robins, et al.
Neurosurgery
|
May 21, 2013
A case series of primary central nervous system posttransplantation lymphoproliferative disorder: imaging and clinical characteristics
Wendell Lake, Julie E Chang, Tabassum Kennedy, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
The Lancet. Haematology
|
September 30, 2017
Maintenance lenalidomide could be most relevant after first-line therapy
Julie E Chang
Drugs
|
November 17, 2011
Current status of targeted therapies for mantle cell lymphoma
Julie E Chang, Brad S Kahl
Current Hematologic Malignancy Reports
|
January 7, 2014
PI3-kinase inhibitors in chronic lymphocytic leukemia
Julie E Chang, Brad S Kahl
Leukemia & Lymphoma
|
January 7, 2012
Bendamustine: more ammunition in the battle against mantle cell lymphoma
Julie E Chang, Brad S Kahl
Clinical Advances in Hematology & Oncology : H&O
|
March 7, 2007
Therapeutic advances in the treatment of brain metastases
Julie E Chang, H Ian Robins, Minesh P Mehta
Clinical Lymphoma, Myeloma & Leukemia
|
June 11, 2011
Regression of Hodgkin lymphoma after discontinuation of a tumor necrosis factor inhibitor for Crohn's disease: a case report and review of the literature
Ryan D Cassaday, Jeffrey T Malik, Julie E Chang
Hematology Reports
|
December 21, 2011
Extranodal NK/T-cell lymphoma presenting with primary cardiac involvement
Lisa M Lepeak, David T Yang, Julie E Chang
Current Cancer Therapy Reviews
|
December 20, 2012
Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment
Ticiana Leal, Julie E Chang, Minesh Mehta, et al.
Clinical Advances in Hematology & Oncology : H&O
|
January 11, 2008
Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme
Julie E Chang, Deepak Khuntia, H Ian Robins, et al.
Neurosurgery
|
May 21, 2013
A case series of primary central nervous system posttransplantation lymphoproliferative disorder: imaging and clinical characteristics
Wendell Lake, Julie E Chang, Tabassum Kennedy, et al.
Page
of 4